Literature DB >> 21567119

Assessment of cardiovascular risk in rheumatoid arthritis: impact of the new EULAR recommendations on the score cardiovascular risk index.

Carmen Gómez-Vaquero1, Montserrat Robustillo, Javier Narváez, Jesús Rodríguez-Moreno, Carlos González-Juanatey, Javier Llorca, Joan Miquel Nolla, Miguel Angel González-Gay.   

Abstract

To assess the impact of the application of the European League against Rheumatism (EULAR) task force recommendations in the cardiovascular (CV) risk of a series of Spanish patients diagnosed with rheumatoid arthritis (RA). Two hundred consecutive RA patients seen at the rheumatology outpatient clinics of Bellvitge Hospital, Barcelona, were studied. Information on clinical features of the disease, classic CV risk factors, and history of CV events was assessed. Both the systematic coronary risk evaluation (SCORE) CV risk index and the modified SCORE (mSCORE) according to the last EULAR recommendations were calculated. Based on the classic CV risk factors, the mean ± standard deviation SCORE was 2.1 ± 2.3% (median, 2; interquartile range [IQR], 1-3). Twenty-three (11%) patients were above the threshold of high CV risk for the Spanish population (≥5%). Following the EULAR recommendations, a change in the score was required in 119 (59%) patients. Therefore, the mean mSCORE was 2.7 ± 2.9% (median, 2; IQR, 1-3) and, due to this, 28 (14%) patients were above the threshold of high CV risk. Nine (5%) had at least one ischemic CV event. Patients with CV events were older and had more CV risk factors and higher SCORE and mSCORE than those without CV events. Although a large proportion of patients from this series fulfilled the criteria for the application of the EULAR recommendations, the final impact on the calculated CV risk was low and clinically significant in only a few patients. However, an association between the mSCORE and the presence of ischemic CV events was observed.

Entities:  

Mesh:

Year:  2011        PMID: 21567119     DOI: 10.1007/s10067-011-1774-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

1.  EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

Authors:  M J L Peters; D P M Symmons; D McCarey; B A C Dijkmans; P Nicola; T K Kvien; I B McInnes; H Haentzschel; M A Gonzalez-Gay; S Provan; A Semb; P Sidiropoulos; G Kitas; Y M Smulders; M Soubrier; Z Szekanecz; N Sattar; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2009-09-22       Impact factor: 19.103

2.  High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis.

Authors:  Miguel A Gonzalez-Gay; Carlos Gonzalez-Juanatey; Angela Piñeiro; Carlos Garcia-Porrua; Ana Testa; Javier Llorca
Journal:  J Rheumatol       Date:  2005-07       Impact factor: 4.666

3.  Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort.

Authors:  Nicola J Goodson; Deborah P M Symmons; David G I Scott; Diane Bunn; Mark Lunt; Alan J Silman
Journal:  Arthritis Rheum       Date:  2005-08

4.  HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis.

Authors:  Miguel A Gonzalez-Gay; Carlos Gonzalez-Juanatey; Maria J Lopez-Diaz; Angela Piñeiro; Carlos Garcia-Porrua; Jose A Miranda-Filloy; William E R Ollier; Javier Martin; Javier Llorca
Journal:  Arthritis Rheum       Date:  2007-02-15

5.  High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors.

Authors:  I D del Rincón; K Williams; M P Stern; G L Freeman; A Escalante
Journal:  Arthritis Rheum       Date:  2001-12

6.  The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years.

Authors:  Paulo J Nicola; Hilal Maradit-Kremers; Véronique L Roger; Steven J Jacobsen; Cynthia S Crowson; Karla V Ballman; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2005-02

7.  Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects.

Authors:  Inmaculada Del Rincón; Ken Williams; Michael P Stern; Gregory L Freeman; Daniel H O'Leary; Agustín Escalante
Journal:  Arthritis Rheum       Date:  2003-07

Review 8.  C-reactive protein: a novel marker of cardiovascular risk.

Authors:  Svati H Shah; L Kristin Newby
Journal:  Cardiol Rev       Date:  2003 Jul-Aug       Impact factor: 2.644

9.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

Authors:  R M Conroy; K Pyörälä; A P Fitzgerald; S Sans; A Menotti; G De Backer; D De Bacquer; P Ducimetière; P Jousilahti; U Keil; I Njølstad; R G Oganov; T Thomsen; H Tunstall-Pedoe; A Tverdal; H Wedel; P Whincup; L Wilhelmsen; I M Graham
Journal:  Eur Heart J       Date:  2003-06       Impact factor: 29.983

10.  Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis.

Authors:  Carlos Gonzalez-Juanatey; Javier Llorca; Javier Martin; Miguel A Gonzalez-Gay
Journal:  Semin Arthritis Rheum       Date:  2008-03-12       Impact factor: 5.532

View more
  8 in total

1.  Prevention of stroke in rheumatoid arthritis.

Authors:  Namrata Dhillon; Kimberly Liang
Journal:  Curr Treat Options Neurol       Date:  2015-07       Impact factor: 3.598

2.  Rheumatoid Arthritis, Anti-Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative.

Authors:  Rachel H Mackey; Lewis H Kuller; Kevin D Deane; Brian T Walitt; Yue-Fang Chang; V Michael Holers; William H Robinson; Russell P Tracy; Mark A Hlatky; Charles B Eaton; Simin Liu; Matthew S Freiberg; Mehret Birru Talabi; Erik B Schelbert; Larry W Moreland
Journal:  Arthritis Rheumatol       Date:  2015-09       Impact factor: 10.995

3.  The improvement in aerobic capacity, disease activity, and function in patients with rheumatoid arthritis following cardiac rehabilitation program: A single-center, controlled study.

Authors:  Hülya Peynirci Cerşit; İlker Yağcı; Sinan Cerşit
Journal:  Turk J Phys Med Rehabil       Date:  2019-04-26

4.  Impact of rheumatoid arthritis on receiving a diagnosis of hypertension among patients with regular primary care.

Authors:  Christie M Bartels; Heather Johnson; Katya Voelker; Carolyn Thorpe; Patrick McBride; Elizabeth A Jacobs; Nancy Pandhi; Maureen Smith
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-09       Impact factor: 4.794

Review 5.  Cardiovascular disease risk scores in the current practice: which to use in rheumatoid arthritis?

Authors:  A Purcarea; S Sovaila; A Gheorghe; G Udrea; V Stoica
Journal:  J Med Life       Date:  2014 Oct-Dec

Review 6.  Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment.

Authors:  Ernest Choy; Kandeepan Ganeshalingam; Anne Grete Semb; Zoltán Szekanecz; Michael Nurmohamed
Journal:  Rheumatology (Oxford)       Date:  2014-06-06       Impact factor: 7.580

7.  Cardiovascular Risks and Risk Stratification in Inflammatory Joint Diseases: A Cross-Sectional Study.

Authors:  Vasyl Yagensky; Michael Schirmer
Journal:  Front Med (Lausanne)       Date:  2022-02-22

8.  Management of hyperlipidemia among patients with rheumatoid arthritis in the primary care setting.

Authors:  Kashif Jafri; Lynne Taylor; Melissa Nezamzadeh; Joshua F Baker; Nehal N Mehta; Christie Bartels; Catherine T Williams; Alexis Ogdie
Journal:  BMC Musculoskelet Disord       Date:  2015-09-03       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.